Cooper Companies (NASDAQ:COO) Stock Price Passes Above 200-Day Moving Average of $90.92

The Cooper Companies, Inc. (NASDAQ:COO) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $90.92 and traded as high as $92.19. Cooper Companies shares last traded at $90.53, with a volume of 1,183,083 shares changing hands.

Analysts Set New Price Targets

COO has been the subject of a number of analyst reports. Redburn Atlantic upgraded Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price target for the company in a research report on Tuesday, March 19th. TheStreet cut shares of Cooper Companies from a “b-” rating to a “c” rating in a research note on Thursday, February 29th. Citigroup raised their target price on shares of Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Mizuho raised their target price on shares of Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Finally, Piper Sandler raised their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Friday, March 1st. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $109.48.

Cooper Companies Price Performance

The company has a debt-to-equity ratio of 0.35, a current ratio of 1.86 and a quick ratio of 1.08. The firm has a fifty day moving average of $97.96 and a two-hundred day moving average of $90.92. The stock has a market capitalization of $17.99 billion, a P/E ratio of 61.90, a P/E/G ratio of 2.37 and a beta of 0.94.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, February 29th. The medical device company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm had revenue of $931.60 million during the quarter, compared to the consensus estimate of $915.93 million. Cooper Companies had a return on equity of 8.79% and a net margin of 7.93%. The firm’s quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the previous year, the company posted $2.90 earnings per share. On average, analysts predict that The Cooper Companies, Inc. will post 3.5 EPS for the current year.

Insiders Place Their Bets

In other news, CAO Agostino Ricupati sold 54,724 shares of the business’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $100.89, for a total transaction of $5,521,104.36. Following the sale, the chief accounting officer now owns 5,081 shares in the company, valued at $512,622.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Gary S. Petersmeyer sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $103.51, for a total value of $103,510.00. Following the sale, the director now owns 5,668 shares in the company, valued at $586,694.68. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Agostino Ricupati sold 54,724 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $100.89, for a total value of $5,521,104.36. Following the completion of the sale, the chief accounting officer now owns 5,081 shares in the company, valued at approximately $512,622.09. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cooper Companies

Hedge funds have recently bought and sold shares of the stock. Handelsbanken Fonder AB raised its stake in shares of Cooper Companies by 6.8% during the 3rd quarter. Handelsbanken Fonder AB now owns 362,154 shares of the medical device company’s stock worth $115,074,000 after buying an additional 23,007 shares during the period. Oak Thistle LLC acquired a new position in shares of Cooper Companies during the 3rd quarter worth approximately $1,114,000. Boston Trust Walden Corp raised its stake in shares of Cooper Companies by 0.4% during the 3rd quarter. Boston Trust Walden Corp now owns 281,916 shares of the medical device company’s stock worth $89,652,000 after buying an additional 1,042 shares during the period. Vontobel Holding Ltd. raised its stake in shares of Cooper Companies by 6.0% during the 3rd quarter. Vontobel Holding Ltd. now owns 2,158 shares of the medical device company’s stock worth $715,000 after buying an additional 122 shares during the period. Finally, Bellecapital International Ltd. raised its stake in shares of Cooper Companies by 0.9% during the 3rd quarter. Bellecapital International Ltd. now owns 12,218 shares of the medical device company’s stock worth $3,885,000 after buying an additional 111 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.